Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 27, 2015 6:01 PM ET

Pharmaceuticals

Company Overview of Actavis plc

Executive Profile

John Alexander Kelly R.Ph.

Chief Communications Officer, Chief Integration Officer and Senior Vice President, Actavis plc
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

----

Background

Mr. John Alexander Kelly, also known as Alex, R.Ph. has been the Chief Communications Officer at Actavis plc since April 20, 2015 and serves as its Chief Integration Officer and Senior Vice President. Prior to that, Mr. Kelly served as the Chief Communications & Investor Relations Officer of Forest Laboratories Inc. since December 2013 and as its Senior Vice President since October 25, 2013. Mr. Kelly served as Chief Communications Officer and Senior Vice President of ...

Corporate Headquarters

Euro House
Little Island, Co. Cork --

Ireland

Phone: 353 21 461 9040
Fax: 353 21 461 9049

Board Members Memberships

There is no Board Members Memberships data available.

Education

BS
Purdue University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Andrew Philip Witty Chief Executive Officer, Executive Director and Member of Finance Committee
GlaxoSmithKline plc
$2.0M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
$15.2M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
$3.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Actavis plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.